IRIS
VERGARO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.655
AS - Asia 12.137
EU - Europa 10.621
SA - Sud America 3.173
AF - Africa 347
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 47.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.680
SG - Singapore 4.584
RU - Federazione Russa 3.190
CN - Cina 3.067
BR - Brasile 2.490
IT - Italia 2.451
VN - Vietnam 1.918
GB - Regno Unito 1.401
HK - Hong Kong 903
DE - Germania 818
CA - Canada 646
FR - Francia 495
UA - Ucraina 469
FI - Finlandia 339
IN - India 288
IE - Irlanda 268
SE - Svezia 251
AR - Argentina 246
MX - Messico 236
BD - Bangladesh 194
NL - Olanda 187
PL - Polonia 182
TR - Turchia 179
ID - Indonesia 159
IQ - Iraq 136
ZA - Sudafrica 128
DK - Danimarca 123
ES - Italia 123
EC - Ecuador 121
IL - Israele 118
JP - Giappone 111
PK - Pakistan 100
AT - Austria 83
CO - Colombia 83
UZ - Uzbekistan 59
MA - Marocco 58
VE - Venezuela 57
AE - Emirati Arabi Uniti 47
PY - Paraguay 47
LT - Lituania 46
CL - Cile 45
PE - Perù 36
SA - Arabia Saudita 35
PH - Filippine 33
EG - Egitto 32
KE - Kenya 29
TN - Tunisia 29
CH - Svizzera 24
UY - Uruguay 23
AZ - Azerbaigian 22
DZ - Algeria 21
EU - Europa 21
BO - Bolivia 20
JO - Giordania 20
AU - Australia 18
BE - Belgio 18
MY - Malesia 17
CR - Costa Rica 16
DO - Repubblica Dominicana 15
RO - Romania 15
KZ - Kazakistan 14
AL - Albania 13
CZ - Repubblica Ceca 13
OM - Oman 13
HN - Honduras 11
NP - Nepal 11
TW - Taiwan 11
HU - Ungheria 10
IR - Iran 10
PA - Panama 10
TH - Thailandia 10
AM - Armenia 9
GR - Grecia 9
SK - Slovacchia (Repubblica Slovacca) 9
JM - Giamaica 8
KW - Kuwait 8
LB - Libano 8
MC - Monaco 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BY - Bielorussia 7
SN - Senegal 7
BB - Barbados 6
BH - Bahrain 6
CG - Congo 6
ET - Etiopia 6
GE - Georgia 6
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
QA - Qatar 6
RS - Serbia 6
SI - Slovenia 6
CI - Costa d'Avorio 5
KR - Corea 5
MK - Macedonia 5
NO - Norvegia 5
PT - Portogallo 5
Totale 47.891
Salva come PNG Salva come JPEG
Città #
Dallas 4.502
Singapore 2.454
Ashburn 1.413
San Jose 1.377
Beijing 1.234
Chicago 1.230
Los Angeles 971
Hong Kong 850
Ho Chi Minh City 617
Moscow 585
Southend 540
Salt Lake City 527
Chandler 443
Fairfield 411
Buffalo 383
Hanoi 373
Houston 334
New York 332
Woodbridge 330
San Mateo 329
Tampa 299
Wilmington 278
The Dalles 274
Seattle 269
São Paulo 261
Dublin 258
Ann Arbor 243
Cambridge 237
Falls Church 232
Elk Grove Village 230
Lauterbourg 230
Hefei 220
Milan 212
Boardman 208
Helsinki 208
Santa Clara 206
Jacksonville 185
Ottawa 183
Council Bluffs 169
Dearborn 162
Rome 159
Pisa 157
Beauharnois 155
Warsaw 155
Portsmouth 153
Orem 146
Munich 145
Stevenage 141
Montreal 131
Sterling 117
Frankfurt am Main 116
Dong Ket 115
Mexico City 113
London 112
Brooklyn 111
Lawrence 106
Lancaster 105
Tel Aviv 105
Florence 101
Tokyo 98
Poplar 95
Amsterdam 93
Denver 91
Istanbul 88
Chennai 87
Johannesburg 86
Rio de Janeiro 85
Phoenix 82
Stockholm 82
Miami 80
Atlanta 77
Da Nang 77
Nuremberg 72
Toronto 69
Dulles 66
Haiphong 59
Belo Horizonte 57
Manchester 55
Tashkent 54
Lappeenranta 53
San Diego 52
Turku 51
Boston 48
Detroit 47
Brasília 46
Washington 46
Kansas City 45
Baghdad 44
Biên Hòa 44
Curitiba 43
Querétaro 43
Bologna 42
Genoa 42
Porto Alegre 42
Quito 41
San Francisco 41
Guangzhou 40
Naples 40
Fremont 39
Guayaquil 39
Totale 28.723
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.832
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.675
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.565
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 698
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 690
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 597
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 395
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 385
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 366
A simple echocardiographic score to rule out cardiac amyloidosis 359
A simple echocardiographic score to rule out cardiac amyloidosis 326
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 322
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 321
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 312
Adrenergic activation in heart failure: blockade or rebalance? 307
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 301
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 299
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 290
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 279
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 279
[Ten perspectives for research and innovation in cardiac amyloidosis] 278
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 277
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 277
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 275
Sex-related differences in chronic heart failure 275
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 273
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 271
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 270
Screening the health status of people working in a university 268
How to take arms against central apneas in heart failure 268
Cardiac light-chain deposition disease relapsing in the transplanted heart 265
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 262
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 261
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 260
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 260
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 259
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 258
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 257
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 256
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 255
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 254
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 252
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 251
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 250
Atrial amyloidosis: mechanisms and clinical manifestations 248
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 248
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 247
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 247
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 247
Biomarkers for the diagnosis and management of heart failure: New frontiers 242
Eligibility for vericiguat in a real‐world, contemporary heart failure population 241
Update sui biomarcatori nello scompenso cardiaco. 241
RNA-targeting and gene editing therapies for transthyretin amyloidosis 239
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 239
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 239
Biomarkers for the diagnosis and management of heart failure 237
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 237
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 236
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 233
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 231
Role of Imaging in Cardiomyopathies 228
Central apnoeas and ticagrelor-related dyspnoea in patients with acute coronary syndrome 226
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 224
Cardiogenic shock and acute kidney injury: the rule rather than the exception 222
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 220
Disease features and management of cardiomyopathies in women 220
Prognostic value of plasma Renin activity in heart failure. 220
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 219
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 219
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 219
The search for efficient diagnostic and prognostic biomarkers of heart failure 218
Correction of procedural arterial pseudoaneurysms: Established and novel procedures 218
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 216
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction 215
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 215
Renin profiling predicts neurohormonal response to sacubitril/valsartan 214
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 213
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 212
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 212
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 211
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 209
Valvular heart disease in patients with cardiac amyloidosis 206
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 205
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 205
Cardiac amyloidosis: Innovations in diagnosis and treatment 204
Tissue Characterization in Cardiac Amyloidosis 203
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 202
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 202
Classification of patients with cardiac amyloidosis using machine learning models on Italian electronic clinical health records 202
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 201
Subclinical cardiac damage in cancer patients before chemotherapy 201
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images 200
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 200
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 200
Molecular autopsy of sudden cardiac death in the genomics era 200
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 198
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 198
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure 198
Valve disease in cardiac amyloidosis: an echocardiographic score 196
Cardiac Amyloidosis: How Its Epidemiology is Changing 195
Totale 30.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021705 0 0 0 0 0 0 0 0 0 151 243 311
2021/20221.911 161 295 80 196 74 67 201 333 141 195 36 132
2022/20231.334 109 110 62 140 164 175 36 120 251 30 82 55
2023/20241.331 76 36 239 101 73 120 102 65 51 75 55 338
2024/202513.502 112 132 487 200 420 489 1.183 2.120 812 2.024 3.134 2.389
2025/202625.458 1.474 4.063 3.958 3.848 2.785 1.803 2.678 1.349 1.806 1.694 0 0
Totale 48.279